SlideShare a Scribd company logo
This document is confidential and contains proprietary information, including trade secrets of CitiusTech. Neither the document nor any of the information
contained in it may be reproduced or disclosed to any unauthorized person under any circumstances without the express written permission of CitiusTech.
19 September, 2017 | Author : Bharadwaj Tanguturi | Healthcare Business Analyst
21st Century Cures Act
and its Impact on Healthcare IT
2
Objectives
 21st Century Cures Act aims to:
• Improve research and innovation where Pharma companies etc. are impacted
• Classify medical devices where medical device companies are impacted
• Hasten Drug Discovery-to-Delivery cycle where FDA, pharma companies etc. are
impacted
• Improve interoperability where hospitals, EHR vendors, HIE etc. are impacted
• Classify Healthcare software where IT consultants, HIT vendors are affected
 This document gives an overview, core objectives of the act and enumerates purpose of
each part / division of the act
 It lists down the sections of the act which have a direct impact on Healthcare IT and
gives a brief overview of each section
 This document also explains the impact of 21st Century Cures Act on regulatory bodies:
FDA / NIH / HSS
3
Agenda
 The 21st Century Cures Act: Overview
 Purpose: Division A/B/C
 Sections Pertaining to HIT
 Sections Pertaining to Penalties
 Impact: On FDA/NIH/HHS
 Key Takeaways
4
Overview
The 21st Century Cures Act (Cures Act), passed into
law in Dec '16, is designed to :
 Promote and fund the acceleration of research
into preventing and curing serious illnesses
 Accelerate drug and medical device
development
 Attempt to address the opioid abuse crisis
 Improve mental health service delivery
Anatomy
The law consists of 3 divisions:
 Division A : 21st Century Cures
 Division B : Helping Families with a Mental
Health Crisis
 Division C : Increasing Choice, Access, and
Quality in Health Care for Americans
The 21st Century Cures Act: Overview
Objectives of the Act
 Advance R&D through better funding medical
innovation projects
 Bring positive changes to the FDA approval
process for drugs & medical devices
 Improve interoperability, privacy, security and
data sharing
 Bring classification into HIT products
 Improve the delivery of mental health services
 Strengthen support to combat opioid abuse
 Introduce mechanisms to speed regulatory
review and bring medicines and devices to
market faster
Affected Stakeholders
 IT vendors: EHR, HIE, RIS, DB vendors
 Regulatory bodies: FDA, NIH etc.
 Medical research institutes
 Medical device companies
 Pharma companies
5
Focus Area Description
 Promote innovation projects like Cancer Moonshot, NIH innovation projects
 Provide guidelines for the state response to the opioid addiction
 Promote National Institutes of Health (NIH) reauthorization and strategy plans
 Initiate Precision Medicine initiative
 Promote research through “Next Generation of Researchers” initiative
 Set privacy protection for human research subjects
 Reduce administrative burden for researchers
 Initiate patient-focused drug development
 Report on patient experience drug development
 Focus on developing lifesaving new drug therapies
 Focus on GAO studies and real world evidence drugs
 Focus on transparent reporting and open sharing of data among stakeholders
 Restrict data blockage by various entities
 Focus on leveraging electronic health records to improve patient care
 Initiate GAO study on patient matching and patient access to health information
 Strengthen the telehealth services in Medicare
Purpose: Division A
Discovery
Development
Delivery
Focuses on faster discovery, development and delivery of lifesaving drugs.
6
Focus Area Description
Strengthening leadership
and accountability
 Improve the quality of behavioral health programs
 Initiate GAO study for programs on mental illness
Ensuring that mental and
substance use disorder
prevention, treatment, and
recovery programs keep pace
with science and technology
 Tackle priority mental health and substance use disorder treatment
needs of regional and national significance
 Encourage evidence-based practices for older adults
 Initiate National violent death reporting system
 Promote assisted outpatient treatment
 Provide mental and behavioral health education, and training grants
Compassionate
communication of HIPAA
 Focus on confidentiality of records
 Initiate clarification on permitted uses and disclosures of PHI
Medicaid mental health
coverage
 Initiate rule of construction for Medicaid coverage of mental health
 Establish study and report on Medicaid managed care regulation
 Provide EPSDT services to children in IMDs
 Promote electronic visit verification system
Purpose: Division B
Addresses the prevention and treatment of mental illnesses and substance abuse, treatment
coverage etc.
7
Purpose: Division C
Focus Area Description
Provisions relating
to Medicare Part A
 Establish beneficiary equity in the Medicare hospital readmission program
 Update the rules on hospital length of stay in all long term stay hospitals
 Bring changes to Medicare classification for certain hospitals
Provisions relating
to Medicare Part B
 Continue Medicare payment under Hospital Outpatient Prospective Payment
System (OPPS)
 Initiate treatment of cancer hospitals in off-campus outpatient department of a
provider policy
 Allow physical therapists to utilize locum tenens arrangements under Medicare
 Initiate extension of the transition to new payment rates for durable medical
equipment
Other Medicare
provisions
 Help with enrollment data reporting for Medicare
 Preserve the Medicare beneficiary choice under Medicare Advantage
 Allow certain beneficiaries to pick a Medicare Advantage plan
 Improve the assignment of beneficiaries under MSSP
Concerns Medicare programs and federal tax laws related to health plans for small employers.
8
Sections Pertaining to HIT (1/4)
Section Key Takeaways
1001 Precision Medicine Initiative (Component 3,4)
 IT systems will have data to help predict most effective treatment for a patient
 EHR can be used for safe and secure data transfer across the Precision Medicine
Initiative
 “All of us” research program:
Volunteers to donate their physical, genomic, EHR based clinical data to NIH for research
 Healthcare IT Interoperability would be used to strengthen Precision Medicine Initiative
3060 Clarifying medical software regulation
 Certain IT systems are not counted as medical devices and won’t be regulated by FDA
4001 Assisting doctors and hospitals in improving quality of care for patients
 Incentives to providers for adoption of meaningful use of certified EHR
 Use of data for value based payment programs
 Health information technology certification for medical and pediatric specialties
 Easy sharing and access of data. Focus on data privacy and security
 Reporting of clinical data for administrative purposes
While all the parts/sections to the law are concerned with U.S Healthcare, specific sections concern
about Healthcare IT. Here are the actual titles and brief descriptions of those sections of the act:
9
Sections Pertaining to HIT (2/4)
Section Key Takeaways
4002 Transparent reporting on usability, security, and functionality
 No restriction on interoperability, usability, etc. for care providers, patients and physicians
 IT vendors to publish APIs and ease exchange of Health Information
 Guidelines for exchange of health Information to encourage higher interoperability
 Exemptions of an eligible hospitals from negative payment adjustments
4003 Interoperability
 Rules for certified vendors to attest claiming for interoperable software
 Develop HIE framework for greater interoperability among EHR/EMR vendors
 It supports digital contact information index
4004 Information blocking
 Penalties for provider/health information exchange engaged in information blocking
 Restrict authorized access, exchange, use of electronic health information and transition
between certified HIT by provider
4005 Leveraging electronic health records to improve patient care
 HIT developer will be working as a provider for purposes of reporting and conducting
patient safety activities
 Improving clinical care through the use of HIT that could result in improved patient safety,
health care quality, or health care outcomes
10
Sections Pertaining to HIT (3/4)
Section Key Takeaways
16003 Treatment of eligible professionals in ambulatory surgical centers for meaningful use and MIPS
 Exemptions for physicians from penalties under EHR incentive programs and MIPS
 Timeline for exemptions from penalties and policies for mandatory EHR
4006 Empowering patients and improving patient access to their electronic health information
 Promote patient access to electronic health information through Health Information Exchanges
 Secure access for their updated electronic health records remotely
 Policies to facilitate patient communication with hospital information system
 Certification & development of patient centric EHR
4007 Government Accountability Office (GAO) Study on patient matching - a study on methods for
securely matching patient records to the respective patient
 Appropriate patient matching to provide secure exchange of health information
 Evaluate current methods for patient matching based on performance related to privacy, security,
improving matching rates, reducing matching errors and reducing duplications
 Define additional data elements to assist with patient matching, and set standards to EHRs to
improve patient matching
11
Sections Pertaining to HIT (4/4)
Section Key Takeaways
4008 GAO (Government Accountability Office) study on patient access to health information
 Improve patient access to PHI (of self) by reducing barriers and complications
 Provide data access to the individual in the form or format requested
4009 Improving Medicare local coverage determinations
 List all Medicare administrative contractors on Medicare internet site
4010 Medicare pharmaceutical and technology ombudsman
 Review of complaints, grievances, and requests on new and life-saving technologies by
Medicare Pharmaceutical and Technology Ombudsman
4011 Medicare site-of-service price transparency
 Website which shows price transparency for outpatient hospital services
4012 Telehealth services in Medicare
 Focus on improvement in quality/efficiency through the expansion of telehealth services
 Suggest critical parameters to ace Telehealth services under Medicare programs
12
Section Title Amount Description Applies to
4004 Penalties for
information
blocking
$1,000,000
(up to) per
violation
Depends on the following factors:
 Nature and extent of the information
blocking
 Harm resulting from information blocking
 The number of patients affected
 The number of providers affected
 The number of days the information
blocking persisted
Healthcare
Information
exchange
/Network
exchange/ EHR
developer
5003 Penalties for
violations of
grants,
contracts
and other
agreements
$10,000 -
$50,000 per
violation
Breakup of the penalty:
 $10,000 per specified claim
 $50,000 for each false statement/
omission/ misrepresentation of a material
fact
 $50,000 for each false record or statement
 $50,000 for each false record or statement
 $15,000/day for the failures
Research
organization/
agency
/scientist/IT
vendor
Sections Pertaining to Penalties
One of the core objectives of the law is to improve data interoperability across IT systems. One of
the way of achieving it is by penalizing data blocking etc. More details on the same are as below:
13
Impact: On FDA
Focus Areas Impact
 Develop a framework for the Real World Evidence program
 Incorporate adaptive designs and statistical modeling into new drug applications
 “Limited population pathway”- expedite antimicrobial drug approvals
 Approvals to new regenerative therapies based on clinical anecdotes and surrogate
endpoints instead of clinically relevant outcomes
 Changes to high-risk (Class-III) medical device approvals by 3rd party instead of FDA
 High-risk medical devices approval based on anecdotal case studies instead of the
usual clinical trials
 Priority review process or fast track review for breakthrough devices
 Breakthrough device approvals within 60 days instead of 300 days (max)
 Reduce HDE (Humanitarian Device Exemption) patient population threshold from
4000 to 8000 patients
 Identify devices that are exempt from reporting requirements (Class-II)
 Out of FDA jurisdiction: Five categories of low-risk software and certain Clinical
Decision Support software
 Accessories shall be classified based on their intended use (and not use parent's
device's classification by default, which is the case currently)
 Exemption of mobile apps if unrelated to the diagnosis/ prevention of diseases
FDA Funding: $80 Million (over 2 years)
Drugs
Devices
Software
14
Impact: On NIH
Focus Areas Impact
 Total Funding: $4.8 billion
 Timeline: Over the next 10 years, beginning in fiscal year 2017
 Breakup of Funding:
• Precision Medicine ($1.45 B)
Initiative for research into the genetic, lifestyle and environmental
variations of disease
• BRAIN Initiative ($1.5 B)
To improve the understanding of diseases like Alzheimer's
• Beau Biden Cancer Moonshot ($1.8B)
To speed up cancer research
• Regenerative medicine ($30M)
 Total Funding: $1 billion
 Timeline: Over the next 2 years, beginning in fiscal year 2017
 Implement measures to reduce the administrative burdens of researchers
 Promote "cutting-edge" research and fund "high-risk, high-reward" projects
Opioid Abuse
Prevention and
Treatment Activities
Other Activities
Big Science Initiative
15
Impact: On HHS
Focus Areas Impact
 EHR Reporting Program for HIT developers to attest their product's security, user-
centered design, interoperability, and real-world functionality
 Propose rules pertaining to EHR interoperability requirements
 Maintain a list of all EHR products on its site to help users choose EHR
 Evaluate current incentive programs to spur increased technology adoption
 Clarify HIPAA privacy rules defining when family members/caregivers can receive
health information on behalf of the patient
 National Provider Digital Index to provide centralized access to all relevant
information for all providers
 Educating stakeholders on their access to electronic health information, including
through HIE, patient portals, or other third-party applications
 Establish Trusted Exchange Framework and related policies to expedite
interoperability among EHRs
HHS Funding: $15 Million (over 4 years)
EHR
Others
16
Key Takeaways
Focus Areas Stakeholders Affected Impact
Penalizing
wrong-doing
EHR Vendors  Impose hefty civil penalties for information blocking / contract
violations etc.
Promoting
research
Pharma Companies  Allocate funds for advanced research, opioid addiction etc.
 Allocate resources towards mental health, including evidence -
based therapies and telehealth services under Medicare
Improvise
drug lifecycle
Pharma Companies  Update drug approval processes for certain antibiotics
 Simplify and expedites Drug approvals
 Safeguard patient privacy in research
Devices Medical Device
companies
 Expedite review process for "breakthrough" technologies
 Accelerate the approval of certain regenerative therapies
 Exemption to certain tracking and reporting software from being
classified as medical devices
Software and
Health IT
systems
Healthcare software
vendors, HIT consultants
 Classification of software and exemption to low-risk software
from FDA approval
 Expedite interoperability among EHRs and improve secure
exchange of health information
17
 https://www.congress.gov/bill/114th-congress/house-bill/34/
 https://www.nihcollaboratory.org/Pages/Grand-Rounds-01-06-17.aspx
 https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmend
mentstotheFDCAct/21stCenturyCuresAct/default.htm
 https://en.wikipedia.org/wiki/21st_Century_Cures_Act
References
18
Thank You
About CitiusTech
2,700+
Healthcare IT professionals worldwide
1,200+
Healthcare software engineers
700+
HL7 certified professionals
30%+
CAGR over last 5 years
80+
Healthcare customers
 Healthcare technology companies
 Hospitals, IDNs & medical groups
 Payers and health plans
 ACO, MCO, HIE, HIX, NHIN and RHIO
 Pharma & Life Sciences companies
Author:
Bharadwaj Tanguturi
Healthcare Business Analyst
thoughtleaders@citiustech.com

More Related Content

What's hot

Impact of HEDIS on Health Plans
Impact of HEDIS on Health PlansImpact of HEDIS on Health Plans
Impact of HEDIS on Health Plans
CitiusTech
 
Artificial Intelligence in Health Care
Artificial Intelligence in Health Care Artificial Intelligence in Health Care
Artificial Intelligence in Health Care
247 Labs Inc
 
His ehr assessment framework v1
His ehr assessment framework v1His ehr assessment framework v1
His ehr assessment framework v1
Pankaj Gupta
 
Big data analytics in healthcare
Big data analytics in healthcareBig data analytics in healthcare
Big data analytics in healthcare
Joseph Thottungal
 
Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...
Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...
Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...
CitiusTech
 
Improving Healthcare Operations Using Process Data Mining
Improving Healthcare Operations Using Process Data Mining Improving Healthcare Operations Using Process Data Mining
Improving Healthcare Operations Using Process Data Mining
Splunk
 
EMR Presentation
EMR PresentationEMR Presentation
EMR Presentation
Jacob Persily
 
Healthcare payer medical informatics and analytics
Healthcare payer medical informatics and analyticsHealthcare payer medical informatics and analytics
Healthcare payer medical informatics and analytics
Frank Wang
 
Electronic Health Records Implementation
Electronic Health Records ImplementationElectronic Health Records Implementation
Electronic Health Records Implementation
Nancy McClanahan, MBA, DHA
 
Accelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World EvidenceAccelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World Evidence
CitiusTech
 
Overview of Hospital Information Systems
Overview of Hospital Information SystemsOverview of Hospital Information Systems
Overview of Hospital Information Systems
Nawanan Theera-Ampornpunt
 
Health Informatics- Module 3-Chapter 1.pptx
Health Informatics- Module 3-Chapter 1.pptxHealth Informatics- Module 3-Chapter 1.pptx
Health Informatics- Module 3-Chapter 1.pptx
Arti Parab Academics
 
E hospital
E hospitalE hospital
E hospital
Suraj Kunhare
 
Al in healthcare
Al in healthcareAl in healthcare
Hospital Information Systems (August 18, 2015)
Hospital Information Systems (August 18, 2015)Hospital Information Systems (August 18, 2015)
Hospital Information Systems (August 18, 2015)
Nawanan Theera-Ampornpunt
 
Risk Management In Pharmacovigilance
Risk Management In PharmacovigilanceRisk Management In Pharmacovigilance
Risk Management In Pharmacovigilance
Rosmirella Cano Rojas
 
The Future of Digital Health in 2022
The Future of Digital Health in 2022The Future of Digital Health in 2022
The Future of Digital Health in 2022
Diana Girnita
 
DIGITAL HEALTH.pptx
DIGITAL HEALTH.pptxDIGITAL HEALTH.pptx
DIGITAL HEALTH.pptx
RINSAVAHEED1
 
The Use of Predictive Analytics in Health Care
The Use of Predictive Analytics in Health CareThe Use of Predictive Analytics in Health Care
The Use of Predictive Analytics in Health Care
jetweedy
 
Introduction to HL7 FHIR
Introduction to HL7 FHIRIntroduction to HL7 FHIR
Introduction to HL7 FHIR
Health Informatics New Zealand
 

What's hot (20)

Impact of HEDIS on Health Plans
Impact of HEDIS on Health PlansImpact of HEDIS on Health Plans
Impact of HEDIS on Health Plans
 
Artificial Intelligence in Health Care
Artificial Intelligence in Health Care Artificial Intelligence in Health Care
Artificial Intelligence in Health Care
 
His ehr assessment framework v1
His ehr assessment framework v1His ehr assessment framework v1
His ehr assessment framework v1
 
Big data analytics in healthcare
Big data analytics in healthcareBig data analytics in healthcare
Big data analytics in healthcare
 
Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...
Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...
Enhancing Competitive Advantage through Improved HEDIS Reporting and NCQA Rat...
 
Improving Healthcare Operations Using Process Data Mining
Improving Healthcare Operations Using Process Data Mining Improving Healthcare Operations Using Process Data Mining
Improving Healthcare Operations Using Process Data Mining
 
EMR Presentation
EMR PresentationEMR Presentation
EMR Presentation
 
Healthcare payer medical informatics and analytics
Healthcare payer medical informatics and analyticsHealthcare payer medical informatics and analytics
Healthcare payer medical informatics and analytics
 
Electronic Health Records Implementation
Electronic Health Records ImplementationElectronic Health Records Implementation
Electronic Health Records Implementation
 
Accelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World EvidenceAccelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World Evidence
 
Overview of Hospital Information Systems
Overview of Hospital Information SystemsOverview of Hospital Information Systems
Overview of Hospital Information Systems
 
Health Informatics- Module 3-Chapter 1.pptx
Health Informatics- Module 3-Chapter 1.pptxHealth Informatics- Module 3-Chapter 1.pptx
Health Informatics- Module 3-Chapter 1.pptx
 
E hospital
E hospitalE hospital
E hospital
 
Al in healthcare
Al in healthcareAl in healthcare
Al in healthcare
 
Hospital Information Systems (August 18, 2015)
Hospital Information Systems (August 18, 2015)Hospital Information Systems (August 18, 2015)
Hospital Information Systems (August 18, 2015)
 
Risk Management In Pharmacovigilance
Risk Management In PharmacovigilanceRisk Management In Pharmacovigilance
Risk Management In Pharmacovigilance
 
The Future of Digital Health in 2022
The Future of Digital Health in 2022The Future of Digital Health in 2022
The Future of Digital Health in 2022
 
DIGITAL HEALTH.pptx
DIGITAL HEALTH.pptxDIGITAL HEALTH.pptx
DIGITAL HEALTH.pptx
 
The Use of Predictive Analytics in Health Care
The Use of Predictive Analytics in Health CareThe Use of Predictive Analytics in Health Care
The Use of Predictive Analytics in Health Care
 
Introduction to HL7 FHIR
Introduction to HL7 FHIRIntroduction to HL7 FHIR
Introduction to HL7 FHIR
 

Similar to 21st Century Act and its Impact on Healthcare IT

BioIT World 2011 eHealth
BioIT World 2011 eHealthBioIT World 2011 eHealth
BioIT World 2011 eHealth
Chris Waller
 
Electronic Health Records - Market Landscape
Electronic Health Records - Market LandscapeElectronic Health Records - Market Landscape
Electronic Health Records - Market Landscape
Harrison Hayes, LLC
 
Implementing EHR in Behavioral Health Blog Post
Implementing EHR in Behavioral Health Blog PostImplementing EHR in Behavioral Health Blog Post
Implementing EHR in Behavioral Health Blog Post
Jeff Brevik, PMP
 
Health Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptxHealth Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptx
Arti Parab Academics
 
Data-driven Healthcare for Providers
Data-driven Healthcare for ProvidersData-driven Healthcare for Providers
Data-driven Healthcare for Providers
LindaWatson19
 
Data driven Healthcare for Providers
Data driven Healthcare for ProvidersData driven Healthcare for Providers
Data driven Healthcare for Providers
Amit Mishra
 
Unit VI Case StudyAnimal use in toxicity testing has long been .docx
Unit VI Case StudyAnimal use in toxicity testing has long been .docxUnit VI Case StudyAnimal use in toxicity testing has long been .docx
Unit VI Case StudyAnimal use in toxicity testing has long been .docx
dickonsondorris
 
hitech act
hitech acthitech act
hitech act
padler01
 
Health Informatics- Module 4-Chapter 3.pptx
Health Informatics- Module 4-Chapter 3.pptxHealth Informatics- Module 4-Chapter 3.pptx
Health Informatics- Module 4-Chapter 3.pptx
Arti Parab Academics
 
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docxAssignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
braycarissa250
 
Healthcare Information Exchange.pdf
Healthcare Information Exchange.pdfHealthcare Information Exchange.pdf
Healthcare Information Exchange.pdf
LarisaAlbanians
 
Hitech Act
Hitech ActHitech Act
Hitech Act
Deborah Obasogie
 
What explains why certain services were covered and others were not .docx
 What explains why certain services were covered and others were not .docx What explains why certain services were covered and others were not .docx
What explains why certain services were covered and others were not .docx
ajoy21
 
Mikhaela ripa
Mikhaela ripaMikhaela ripa
Mikhaela ripa
emerosegal
 
Issues in informatics
Issues in informaticsIssues in informatics
Issues in informatics
loveobi25
 
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx
priestmanmable
 
Health information management system by dr. protik.pptx
Health information management system by dr. protik.pptxHealth information management system by dr. protik.pptx
Health information management system by dr. protik.pptx
Protik Banik
 
Ethics, Informatics and Obamacare
Ethics, Informatics and ObamacareEthics, Informatics and Obamacare
Ethics, Informatics and Obamacare
Barry Smith
 
Personal Health Records
Personal Health RecordsPersonal Health Records
Personal Health Records
RRR784
 
Poster Peg And Sirisha Final
Poster   Peg And Sirisha FinalPoster   Peg And Sirisha Final
Poster Peg And Sirisha Final
pegscheible
 

Similar to 21st Century Act and its Impact on Healthcare IT (20)

BioIT World 2011 eHealth
BioIT World 2011 eHealthBioIT World 2011 eHealth
BioIT World 2011 eHealth
 
Electronic Health Records - Market Landscape
Electronic Health Records - Market LandscapeElectronic Health Records - Market Landscape
Electronic Health Records - Market Landscape
 
Implementing EHR in Behavioral Health Blog Post
Implementing EHR in Behavioral Health Blog PostImplementing EHR in Behavioral Health Blog Post
Implementing EHR in Behavioral Health Blog Post
 
Health Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptxHealth Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptx
 
Data-driven Healthcare for Providers
Data-driven Healthcare for ProvidersData-driven Healthcare for Providers
Data-driven Healthcare for Providers
 
Data driven Healthcare for Providers
Data driven Healthcare for ProvidersData driven Healthcare for Providers
Data driven Healthcare for Providers
 
Unit VI Case StudyAnimal use in toxicity testing has long been .docx
Unit VI Case StudyAnimal use in toxicity testing has long been .docxUnit VI Case StudyAnimal use in toxicity testing has long been .docx
Unit VI Case StudyAnimal use in toxicity testing has long been .docx
 
hitech act
hitech acthitech act
hitech act
 
Health Informatics- Module 4-Chapter 3.pptx
Health Informatics- Module 4-Chapter 3.pptxHealth Informatics- Module 4-Chapter 3.pptx
Health Informatics- Module 4-Chapter 3.pptx
 
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docxAssignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
 
Healthcare Information Exchange.pdf
Healthcare Information Exchange.pdfHealthcare Information Exchange.pdf
Healthcare Information Exchange.pdf
 
Hitech Act
Hitech ActHitech Act
Hitech Act
 
What explains why certain services were covered and others were not .docx
 What explains why certain services were covered and others were not .docx What explains why certain services were covered and others were not .docx
What explains why certain services were covered and others were not .docx
 
Mikhaela ripa
Mikhaela ripaMikhaela ripa
Mikhaela ripa
 
Issues in informatics
Issues in informaticsIssues in informatics
Issues in informatics
 
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docx
 
Health information management system by dr. protik.pptx
Health information management system by dr. protik.pptxHealth information management system by dr. protik.pptx
Health information management system by dr. protik.pptx
 
Ethics, Informatics and Obamacare
Ethics, Informatics and ObamacareEthics, Informatics and Obamacare
Ethics, Informatics and Obamacare
 
Personal Health Records
Personal Health RecordsPersonal Health Records
Personal Health Records
 
Poster Peg And Sirisha Final
Poster   Peg And Sirisha FinalPoster   Peg And Sirisha Final
Poster Peg And Sirisha Final
 

More from CitiusTech

Member Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health PlansMember Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health Plans
CitiusTech
 
Evolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in HealthcareEvolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in Healthcare
CitiusTech
 
Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations
CitiusTech
 
Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)
CitiusTech
 
CMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An AnalysisCMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An Analysis
CitiusTech
 
Accelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOpsAccelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOps
CitiusTech
 
FHIR for Life Sciences
FHIR for Life SciencesFHIR for Life Sciences
FHIR for Life Sciences
CitiusTech
 
Leveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk PatientsLeveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk Patients
CitiusTech
 
FHIR Adoption Framework for Payers
FHIR Adoption Framework for PayersFHIR Adoption Framework for Payers
FHIR Adoption Framework for Payers
CitiusTech
 
Payer-Provider Engagement
Payer-Provider Engagement Payer-Provider Engagement
Payer-Provider Engagement
CitiusTech
 
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
CitiusTech
 
Demystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation TestingDemystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation Testing
CitiusTech
 
Progressive Web Apps in Healthcare
Progressive Web Apps in HealthcareProgressive Web Apps in Healthcare
Progressive Web Apps in Healthcare
CitiusTech
 
RPA in Healthcare
RPA in HealthcareRPA in Healthcare
RPA in Healthcare
CitiusTech
 
6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP
CitiusTech
 
Opioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureOpioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and Future
CitiusTech
 
Rising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes ResearchRising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes Research
CitiusTech
 
ICD 11: Impact on Payer Market
ICD 11: Impact on Payer MarketICD 11: Impact on Payer Market
ICD 11: Impact on Payer Market
CitiusTech
 
Testing Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on HadoopTesting Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on Hadoop
CitiusTech
 
Driving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data AnalyticsDriving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data Analytics
CitiusTech
 

More from CitiusTech (20)

Member Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health PlansMember Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health Plans
 
Evolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in HealthcareEvolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in Healthcare
 
Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations
 
Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)
 
CMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An AnalysisCMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An Analysis
 
Accelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOpsAccelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOps
 
FHIR for Life Sciences
FHIR for Life SciencesFHIR for Life Sciences
FHIR for Life Sciences
 
Leveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk PatientsLeveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk Patients
 
FHIR Adoption Framework for Payers
FHIR Adoption Framework for PayersFHIR Adoption Framework for Payers
FHIR Adoption Framework for Payers
 
Payer-Provider Engagement
Payer-Provider Engagement Payer-Provider Engagement
Payer-Provider Engagement
 
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
 
Demystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation TestingDemystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation Testing
 
Progressive Web Apps in Healthcare
Progressive Web Apps in HealthcareProgressive Web Apps in Healthcare
Progressive Web Apps in Healthcare
 
RPA in Healthcare
RPA in HealthcareRPA in Healthcare
RPA in Healthcare
 
6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP
 
Opioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureOpioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and Future
 
Rising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes ResearchRising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes Research
 
ICD 11: Impact on Payer Market
ICD 11: Impact on Payer MarketICD 11: Impact on Payer Market
ICD 11: Impact on Payer Market
 
Testing Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on HadoopTesting Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on Hadoop
 
Driving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data AnalyticsDriving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data Analytics
 

Recently uploaded

Drugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor Drugs
Drugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor DrugsDrugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor Drugs
Drugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor Drugs
sanjayudps2016
 
Understanding Motivational Interviewing.pdf
Understanding Motivational Interviewing.pdfUnderstanding Motivational Interviewing.pdf
Understanding Motivational Interviewing.pdf
premiermentalhealth
 
World Health Organization Guidelines on Nutrition .pptx
World Health Organization Guidelines on Nutrition .pptxWorld Health Organization Guidelines on Nutrition .pptx
World Health Organization Guidelines on Nutrition .pptx
MopideviSravani
 
Inflammation.pptx (type , cellular event of infllmation .etc)
Inflammation.pptx (type , cellular event of infllmation .etc)Inflammation.pptx (type , cellular event of infllmation .etc)
Inflammation.pptx (type , cellular event of infllmation .etc)
AviralSharma91
 
Smart Hospitals
Smart HospitalsSmart Hospitals
Smart Hospitals
Dr. Salem Baidas
 
Enhancing Patient Safety in Digital Therapeutics: AI- Driven Approaches
Enhancing Patient Safety in Digital Therapeutics: AI- Driven ApproachesEnhancing Patient Safety in Digital Therapeutics: AI- Driven Approaches
Enhancing Patient Safety in Digital Therapeutics: AI- Driven Approaches
ClinosolIndia
 
New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...
New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...
New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...
revolutionary575
 
Top Companies Empowering Access to Healthcare 2024.pdf
Top Companies Empowering Access to Healthcare 2024.pdfTop Companies Empowering Access to Healthcare 2024.pdf
Top Companies Empowering Access to Healthcare 2024.pdf
insightscare
 
BURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdf
BURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdfBURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdf
BURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdf
Dolisha Warbi
 
Outsourced Healthcare Billing Services - Velan hcs.pdf
Outsourced Healthcare Billing Services - Velan hcs.pdfOutsourced Healthcare Billing Services - Velan hcs.pdf
Outsourced Healthcare Billing Services - Velan hcs.pdf
VelanHcs
 
ALTERNATIVE THERAPIES DURING LABOUR.pptx
ALTERNATIVE THERAPIES DURING LABOUR.pptxALTERNATIVE THERAPIES DURING LABOUR.pptx
ALTERNATIVE THERAPIES DURING LABOUR.pptx
BhagyashreeDash6
 
Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...
Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...
Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...
bellared2
 
Bronchiectasis and Physiotherapy Management
Bronchiectasis and Physiotherapy ManagementBronchiectasis and Physiotherapy Management
Bronchiectasis and Physiotherapy Management
abdulazeezvpadikkal
 
Case Study of intestinal Obstruction.docx
Case Study of intestinal Obstruction.docxCase Study of intestinal Obstruction.docx
Case Study of intestinal Obstruction.docx
BeCreative6
 
Mind Sound Resonance Technique (MSRT) Certificate Course.ppt
Mind Sound Resonance Technique (MSRT) Certificate Course.pptMind Sound Resonance Technique (MSRT) Certificate Course.ppt
Mind Sound Resonance Technique (MSRT) Certificate Course.ppt
Karuna Yoga Vidya Peetham
 
Provider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptx
Provider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptxProvider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptx
Provider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptx
abhi916jith
 
CCN case study Muhammad alam (pleural effusion)-1.docx
CCN case study Muhammad alam (pleural effusion)-1.docxCCN case study Muhammad alam (pleural effusion)-1.docx
CCN case study Muhammad alam (pleural effusion)-1.docx
BeCreative6
 
Massage Centre Ajman - Malayali Kerala Spa Ajman
Massage Centre Ajman - Malayali Kerala Spa AjmanMassage Centre Ajman - Malayali Kerala Spa Ajman
Massage Centre Ajman - Malayali Kerala Spa Ajman
Malayali Kerala Spa Ajman
 
Innovations in Hair Loss Treatment: The Role of R3 Stem Cell
Innovations in Hair Loss Treatment: The Role of R3 Stem CellInnovations in Hair Loss Treatment: The Role of R3 Stem Cell
Innovations in Hair Loss Treatment: The Role of R3 Stem Cell
R3 Stem Cell
 
16 July 24 Going for gold awards ceremony slides
16 July 24 Going for gold awards ceremony slides16 July 24 Going for gold awards ceremony slides
16 July 24 Going for gold awards ceremony slides
ILC- UK
 

Recently uploaded (20)

Drugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor Drugs
Drugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor DrugsDrugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor Drugs
Drugs Used for the Hyperlipidemic drugs, HMG-CoA Reductase Inhibitor Drugs
 
Understanding Motivational Interviewing.pdf
Understanding Motivational Interviewing.pdfUnderstanding Motivational Interviewing.pdf
Understanding Motivational Interviewing.pdf
 
World Health Organization Guidelines on Nutrition .pptx
World Health Organization Guidelines on Nutrition .pptxWorld Health Organization Guidelines on Nutrition .pptx
World Health Organization Guidelines on Nutrition .pptx
 
Inflammation.pptx (type , cellular event of infllmation .etc)
Inflammation.pptx (type , cellular event of infllmation .etc)Inflammation.pptx (type , cellular event of infllmation .etc)
Inflammation.pptx (type , cellular event of infllmation .etc)
 
Smart Hospitals
Smart HospitalsSmart Hospitals
Smart Hospitals
 
Enhancing Patient Safety in Digital Therapeutics: AI- Driven Approaches
Enhancing Patient Safety in Digital Therapeutics: AI- Driven ApproachesEnhancing Patient Safety in Digital Therapeutics: AI- Driven Approaches
Enhancing Patient Safety in Digital Therapeutics: AI- Driven Approaches
 
New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...
New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...
New Girls Call Navi Mumbai 9930245274 Unlimited Short Providing Girls Service...
 
Top Companies Empowering Access to Healthcare 2024.pdf
Top Companies Empowering Access to Healthcare 2024.pdfTop Companies Empowering Access to Healthcare 2024.pdf
Top Companies Empowering Access to Healthcare 2024.pdf
 
BURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdf
BURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdfBURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdf
BURNS, CALCULATION OF BURNS, CALCULATION OF FLUID REQUIREMENT AND MANAGEMENT.pdf
 
Outsourced Healthcare Billing Services - Velan hcs.pdf
Outsourced Healthcare Billing Services - Velan hcs.pdfOutsourced Healthcare Billing Services - Velan hcs.pdf
Outsourced Healthcare Billing Services - Velan hcs.pdf
 
ALTERNATIVE THERAPIES DURING LABOUR.pptx
ALTERNATIVE THERAPIES DURING LABOUR.pptxALTERNATIVE THERAPIES DURING LABOUR.pptx
ALTERNATIVE THERAPIES DURING LABOUR.pptx
 
Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...
Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...
Female Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Serv...
 
Bronchiectasis and Physiotherapy Management
Bronchiectasis and Physiotherapy ManagementBronchiectasis and Physiotherapy Management
Bronchiectasis and Physiotherapy Management
 
Case Study of intestinal Obstruction.docx
Case Study of intestinal Obstruction.docxCase Study of intestinal Obstruction.docx
Case Study of intestinal Obstruction.docx
 
Mind Sound Resonance Technique (MSRT) Certificate Course.ppt
Mind Sound Resonance Technique (MSRT) Certificate Course.pptMind Sound Resonance Technique (MSRT) Certificate Course.ppt
Mind Sound Resonance Technique (MSRT) Certificate Course.ppt
 
Provider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptx
Provider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptxProvider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptx
Provider training_2nd _Addendum 41 to DOH Claims & Adjudication Rules (1).pptx
 
CCN case study Muhammad alam (pleural effusion)-1.docx
CCN case study Muhammad alam (pleural effusion)-1.docxCCN case study Muhammad alam (pleural effusion)-1.docx
CCN case study Muhammad alam (pleural effusion)-1.docx
 
Massage Centre Ajman - Malayali Kerala Spa Ajman
Massage Centre Ajman - Malayali Kerala Spa AjmanMassage Centre Ajman - Malayali Kerala Spa Ajman
Massage Centre Ajman - Malayali Kerala Spa Ajman
 
Innovations in Hair Loss Treatment: The Role of R3 Stem Cell
Innovations in Hair Loss Treatment: The Role of R3 Stem CellInnovations in Hair Loss Treatment: The Role of R3 Stem Cell
Innovations in Hair Loss Treatment: The Role of R3 Stem Cell
 
16 July 24 Going for gold awards ceremony slides
16 July 24 Going for gold awards ceremony slides16 July 24 Going for gold awards ceremony slides
16 July 24 Going for gold awards ceremony slides
 

21st Century Act and its Impact on Healthcare IT

  • 1. This document is confidential and contains proprietary information, including trade secrets of CitiusTech. Neither the document nor any of the information contained in it may be reproduced or disclosed to any unauthorized person under any circumstances without the express written permission of CitiusTech. 19 September, 2017 | Author : Bharadwaj Tanguturi | Healthcare Business Analyst 21st Century Cures Act and its Impact on Healthcare IT
  • 2. 2 Objectives  21st Century Cures Act aims to: • Improve research and innovation where Pharma companies etc. are impacted • Classify medical devices where medical device companies are impacted • Hasten Drug Discovery-to-Delivery cycle where FDA, pharma companies etc. are impacted • Improve interoperability where hospitals, EHR vendors, HIE etc. are impacted • Classify Healthcare software where IT consultants, HIT vendors are affected  This document gives an overview, core objectives of the act and enumerates purpose of each part / division of the act  It lists down the sections of the act which have a direct impact on Healthcare IT and gives a brief overview of each section  This document also explains the impact of 21st Century Cures Act on regulatory bodies: FDA / NIH / HSS
  • 3. 3 Agenda  The 21st Century Cures Act: Overview  Purpose: Division A/B/C  Sections Pertaining to HIT  Sections Pertaining to Penalties  Impact: On FDA/NIH/HHS  Key Takeaways
  • 4. 4 Overview The 21st Century Cures Act (Cures Act), passed into law in Dec '16, is designed to :  Promote and fund the acceleration of research into preventing and curing serious illnesses  Accelerate drug and medical device development  Attempt to address the opioid abuse crisis  Improve mental health service delivery Anatomy The law consists of 3 divisions:  Division A : 21st Century Cures  Division B : Helping Families with a Mental Health Crisis  Division C : Increasing Choice, Access, and Quality in Health Care for Americans The 21st Century Cures Act: Overview Objectives of the Act  Advance R&D through better funding medical innovation projects  Bring positive changes to the FDA approval process for drugs & medical devices  Improve interoperability, privacy, security and data sharing  Bring classification into HIT products  Improve the delivery of mental health services  Strengthen support to combat opioid abuse  Introduce mechanisms to speed regulatory review and bring medicines and devices to market faster Affected Stakeholders  IT vendors: EHR, HIE, RIS, DB vendors  Regulatory bodies: FDA, NIH etc.  Medical research institutes  Medical device companies  Pharma companies
  • 5. 5 Focus Area Description  Promote innovation projects like Cancer Moonshot, NIH innovation projects  Provide guidelines for the state response to the opioid addiction  Promote National Institutes of Health (NIH) reauthorization and strategy plans  Initiate Precision Medicine initiative  Promote research through “Next Generation of Researchers” initiative  Set privacy protection for human research subjects  Reduce administrative burden for researchers  Initiate patient-focused drug development  Report on patient experience drug development  Focus on developing lifesaving new drug therapies  Focus on GAO studies and real world evidence drugs  Focus on transparent reporting and open sharing of data among stakeholders  Restrict data blockage by various entities  Focus on leveraging electronic health records to improve patient care  Initiate GAO study on patient matching and patient access to health information  Strengthen the telehealth services in Medicare Purpose: Division A Discovery Development Delivery Focuses on faster discovery, development and delivery of lifesaving drugs.
  • 6. 6 Focus Area Description Strengthening leadership and accountability  Improve the quality of behavioral health programs  Initiate GAO study for programs on mental illness Ensuring that mental and substance use disorder prevention, treatment, and recovery programs keep pace with science and technology  Tackle priority mental health and substance use disorder treatment needs of regional and national significance  Encourage evidence-based practices for older adults  Initiate National violent death reporting system  Promote assisted outpatient treatment  Provide mental and behavioral health education, and training grants Compassionate communication of HIPAA  Focus on confidentiality of records  Initiate clarification on permitted uses and disclosures of PHI Medicaid mental health coverage  Initiate rule of construction for Medicaid coverage of mental health  Establish study and report on Medicaid managed care regulation  Provide EPSDT services to children in IMDs  Promote electronic visit verification system Purpose: Division B Addresses the prevention and treatment of mental illnesses and substance abuse, treatment coverage etc.
  • 7. 7 Purpose: Division C Focus Area Description Provisions relating to Medicare Part A  Establish beneficiary equity in the Medicare hospital readmission program  Update the rules on hospital length of stay in all long term stay hospitals  Bring changes to Medicare classification for certain hospitals Provisions relating to Medicare Part B  Continue Medicare payment under Hospital Outpatient Prospective Payment System (OPPS)  Initiate treatment of cancer hospitals in off-campus outpatient department of a provider policy  Allow physical therapists to utilize locum tenens arrangements under Medicare  Initiate extension of the transition to new payment rates for durable medical equipment Other Medicare provisions  Help with enrollment data reporting for Medicare  Preserve the Medicare beneficiary choice under Medicare Advantage  Allow certain beneficiaries to pick a Medicare Advantage plan  Improve the assignment of beneficiaries under MSSP Concerns Medicare programs and federal tax laws related to health plans for small employers.
  • 8. 8 Sections Pertaining to HIT (1/4) Section Key Takeaways 1001 Precision Medicine Initiative (Component 3,4)  IT systems will have data to help predict most effective treatment for a patient  EHR can be used for safe and secure data transfer across the Precision Medicine Initiative  “All of us” research program: Volunteers to donate their physical, genomic, EHR based clinical data to NIH for research  Healthcare IT Interoperability would be used to strengthen Precision Medicine Initiative 3060 Clarifying medical software regulation  Certain IT systems are not counted as medical devices and won’t be regulated by FDA 4001 Assisting doctors and hospitals in improving quality of care for patients  Incentives to providers for adoption of meaningful use of certified EHR  Use of data for value based payment programs  Health information technology certification for medical and pediatric specialties  Easy sharing and access of data. Focus on data privacy and security  Reporting of clinical data for administrative purposes While all the parts/sections to the law are concerned with U.S Healthcare, specific sections concern about Healthcare IT. Here are the actual titles and brief descriptions of those sections of the act:
  • 9. 9 Sections Pertaining to HIT (2/4) Section Key Takeaways 4002 Transparent reporting on usability, security, and functionality  No restriction on interoperability, usability, etc. for care providers, patients and physicians  IT vendors to publish APIs and ease exchange of Health Information  Guidelines for exchange of health Information to encourage higher interoperability  Exemptions of an eligible hospitals from negative payment adjustments 4003 Interoperability  Rules for certified vendors to attest claiming for interoperable software  Develop HIE framework for greater interoperability among EHR/EMR vendors  It supports digital contact information index 4004 Information blocking  Penalties for provider/health information exchange engaged in information blocking  Restrict authorized access, exchange, use of electronic health information and transition between certified HIT by provider 4005 Leveraging electronic health records to improve patient care  HIT developer will be working as a provider for purposes of reporting and conducting patient safety activities  Improving clinical care through the use of HIT that could result in improved patient safety, health care quality, or health care outcomes
  • 10. 10 Sections Pertaining to HIT (3/4) Section Key Takeaways 16003 Treatment of eligible professionals in ambulatory surgical centers for meaningful use and MIPS  Exemptions for physicians from penalties under EHR incentive programs and MIPS  Timeline for exemptions from penalties and policies for mandatory EHR 4006 Empowering patients and improving patient access to their electronic health information  Promote patient access to electronic health information through Health Information Exchanges  Secure access for their updated electronic health records remotely  Policies to facilitate patient communication with hospital information system  Certification & development of patient centric EHR 4007 Government Accountability Office (GAO) Study on patient matching - a study on methods for securely matching patient records to the respective patient  Appropriate patient matching to provide secure exchange of health information  Evaluate current methods for patient matching based on performance related to privacy, security, improving matching rates, reducing matching errors and reducing duplications  Define additional data elements to assist with patient matching, and set standards to EHRs to improve patient matching
  • 11. 11 Sections Pertaining to HIT (4/4) Section Key Takeaways 4008 GAO (Government Accountability Office) study on patient access to health information  Improve patient access to PHI (of self) by reducing barriers and complications  Provide data access to the individual in the form or format requested 4009 Improving Medicare local coverage determinations  List all Medicare administrative contractors on Medicare internet site 4010 Medicare pharmaceutical and technology ombudsman  Review of complaints, grievances, and requests on new and life-saving technologies by Medicare Pharmaceutical and Technology Ombudsman 4011 Medicare site-of-service price transparency  Website which shows price transparency for outpatient hospital services 4012 Telehealth services in Medicare  Focus on improvement in quality/efficiency through the expansion of telehealth services  Suggest critical parameters to ace Telehealth services under Medicare programs
  • 12. 12 Section Title Amount Description Applies to 4004 Penalties for information blocking $1,000,000 (up to) per violation Depends on the following factors:  Nature and extent of the information blocking  Harm resulting from information blocking  The number of patients affected  The number of providers affected  The number of days the information blocking persisted Healthcare Information exchange /Network exchange/ EHR developer 5003 Penalties for violations of grants, contracts and other agreements $10,000 - $50,000 per violation Breakup of the penalty:  $10,000 per specified claim  $50,000 for each false statement/ omission/ misrepresentation of a material fact  $50,000 for each false record or statement  $50,000 for each false record or statement  $15,000/day for the failures Research organization/ agency /scientist/IT vendor Sections Pertaining to Penalties One of the core objectives of the law is to improve data interoperability across IT systems. One of the way of achieving it is by penalizing data blocking etc. More details on the same are as below:
  • 13. 13 Impact: On FDA Focus Areas Impact  Develop a framework for the Real World Evidence program  Incorporate adaptive designs and statistical modeling into new drug applications  “Limited population pathway”- expedite antimicrobial drug approvals  Approvals to new regenerative therapies based on clinical anecdotes and surrogate endpoints instead of clinically relevant outcomes  Changes to high-risk (Class-III) medical device approvals by 3rd party instead of FDA  High-risk medical devices approval based on anecdotal case studies instead of the usual clinical trials  Priority review process or fast track review for breakthrough devices  Breakthrough device approvals within 60 days instead of 300 days (max)  Reduce HDE (Humanitarian Device Exemption) patient population threshold from 4000 to 8000 patients  Identify devices that are exempt from reporting requirements (Class-II)  Out of FDA jurisdiction: Five categories of low-risk software and certain Clinical Decision Support software  Accessories shall be classified based on their intended use (and not use parent's device's classification by default, which is the case currently)  Exemption of mobile apps if unrelated to the diagnosis/ prevention of diseases FDA Funding: $80 Million (over 2 years) Drugs Devices Software
  • 14. 14 Impact: On NIH Focus Areas Impact  Total Funding: $4.8 billion  Timeline: Over the next 10 years, beginning in fiscal year 2017  Breakup of Funding: • Precision Medicine ($1.45 B) Initiative for research into the genetic, lifestyle and environmental variations of disease • BRAIN Initiative ($1.5 B) To improve the understanding of diseases like Alzheimer's • Beau Biden Cancer Moonshot ($1.8B) To speed up cancer research • Regenerative medicine ($30M)  Total Funding: $1 billion  Timeline: Over the next 2 years, beginning in fiscal year 2017  Implement measures to reduce the administrative burdens of researchers  Promote "cutting-edge" research and fund "high-risk, high-reward" projects Opioid Abuse Prevention and Treatment Activities Other Activities Big Science Initiative
  • 15. 15 Impact: On HHS Focus Areas Impact  EHR Reporting Program for HIT developers to attest their product's security, user- centered design, interoperability, and real-world functionality  Propose rules pertaining to EHR interoperability requirements  Maintain a list of all EHR products on its site to help users choose EHR  Evaluate current incentive programs to spur increased technology adoption  Clarify HIPAA privacy rules defining when family members/caregivers can receive health information on behalf of the patient  National Provider Digital Index to provide centralized access to all relevant information for all providers  Educating stakeholders on their access to electronic health information, including through HIE, patient portals, or other third-party applications  Establish Trusted Exchange Framework and related policies to expedite interoperability among EHRs HHS Funding: $15 Million (over 4 years) EHR Others
  • 16. 16 Key Takeaways Focus Areas Stakeholders Affected Impact Penalizing wrong-doing EHR Vendors  Impose hefty civil penalties for information blocking / contract violations etc. Promoting research Pharma Companies  Allocate funds for advanced research, opioid addiction etc.  Allocate resources towards mental health, including evidence - based therapies and telehealth services under Medicare Improvise drug lifecycle Pharma Companies  Update drug approval processes for certain antibiotics  Simplify and expedites Drug approvals  Safeguard patient privacy in research Devices Medical Device companies  Expedite review process for "breakthrough" technologies  Accelerate the approval of certain regenerative therapies  Exemption to certain tracking and reporting software from being classified as medical devices Software and Health IT systems Healthcare software vendors, HIT consultants  Classification of software and exemption to low-risk software from FDA approval  Expedite interoperability among EHRs and improve secure exchange of health information
  • 17. 17  https://www.congress.gov/bill/114th-congress/house-bill/34/  https://www.nihcollaboratory.org/Pages/Grand-Rounds-01-06-17.aspx  https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmend mentstotheFDCAct/21stCenturyCuresAct/default.htm  https://en.wikipedia.org/wiki/21st_Century_Cures_Act References
  • 18. 18 Thank You About CitiusTech 2,700+ Healthcare IT professionals worldwide 1,200+ Healthcare software engineers 700+ HL7 certified professionals 30%+ CAGR over last 5 years 80+ Healthcare customers  Healthcare technology companies  Hospitals, IDNs & medical groups  Payers and health plans  ACO, MCO, HIE, HIX, NHIN and RHIO  Pharma & Life Sciences companies Author: Bharadwaj Tanguturi Healthcare Business Analyst thoughtleaders@citiustech.com